Editorial
New-onset Crohn’s disease after secukinumab treatment
Clinical Rheumatology · 2026-08 · 45 (8) · 5125-5126
DOI: 10.1007/s10067-026-08209-5 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical Rheumatology, online erschienen am 06.06.2026. Verfasst von Ya-Chih Tien. Beteiligte Einrichtung: Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, 135 Nanxiao Street, Changhua City, 50…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, 135 Nanxiao Street, Changhua City, 500-06, Taiwan. 143973@cch.org.tw.
Zitieren
APA
Tien, Y. C. (2026). New-onset Crohn’s disease after secukinumab treatment. Clinical Rheumatology, 45(8), 5125-5126. https://doi.org/10.1007/s10067-026-08209-5
Vancouver
Tien YC. New-onset Crohn’s disease after secukinumab treatment. Clinical Rheumatology. 2026;45(8):5125-5126. doi:10.1007/s10067-026-08209-5
BibTeX
@article{Tien2026,
author = {Tien, Ya-Chih},
title = {New-onset Crohn’s disease after secukinumab treatment},
journal = {Clinical Rheumatology},
year = {2026},
volume = {45},
number = {8},
pages = {5125--5126},
doi = {10.1007/s10067-026-08209-5}
}
EUVIMED